117 related articles for article (PubMed ID: 35787483)
1. Bilirubin increases viability and decreases osteoclast apoptosis contributing to osteoporosis in advanced liver diseases.
Jurado S; Parés A; Peris P; Combalia A; Monegal A; Guañabens N
Bone; 2022 Sep; 162():116483. PubMed ID: 35787483
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis.
Ruiz-Gaspà S; Dubreuil M; Guañabens N; Combalia A; Peris P; Monegal A; Parés A
Eur J Clin Invest; 2014 Dec; 44(12):1206-14. PubMed ID: 25331234
[TBL] [Abstract][Full Text] [Related]
3. Bile acids and bilirubin effects on osteoblastic gene profile. Implications in the pathogenesis of osteoporosis in liver diseases.
Ruiz-Gaspà S; Guañabens N; Jurado S; Dubreuil M; Combalia A; Peris P; Monegal A; Parés A
Gene; 2020 Jan; 725():144167. PubMed ID: 31639434
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells.
Dubreuil M; Ruiz-Gaspà S; Guañabens N; Peris P; Alvarez L; Monegal A; Combalia A; Parés A
Liver Int; 2013 Aug; 33(7):1029-38. PubMed ID: 23560764
[TBL] [Abstract][Full Text] [Related]
5. Bilirubin and bile acids in osteocytes and bone tissue. Potential role in the cholestatic-induced osteoporosis.
Ruiz-Gaspà S; Guañabens N; Jurado S; Combalia A; Peris P; Monegal A; Parés A
Liver Int; 2020 Nov; 40(11):2767-2775. PubMed ID: 32749754
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-539 promotes osteoblast proliferation and differentiation and osteoclast apoptosis through the AXNA-dependent Wnt signaling pathway in osteoporotic rats.
Zhu XB; Lin WJ; Lv C; Wang L; Huang ZX; Yang SW; Chen X
J Cell Biochem; 2018 Nov; 119(10):8346-8358. PubMed ID: 29893431
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-29a represses osteoclast formation and protects against osteoporosis by regulating PCAF-mediated RANKL and CXCL12.
Lian WS; Ko JY; Chen YS; Ke HJ; Hsieh CK; Kuo CW; Wang SY; Huang BW; Tseng JG; Wang FS
Cell Death Dis; 2019 Sep; 10(10):705. PubMed ID: 31543513
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting.
Zhang XH; Geng GL; Su B; Liang CP; Wang F; Bao JC
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706599
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast signaling-targeting miR-146a-3p and miR-155-5p are downregulated in Paget's disease of bone.
Stephens E; Roy M; Bisson M; Nguyen HD; Scott MS; Boire G; Bouchard L; Roux S
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165852. PubMed ID: 32485219
[TBL] [Abstract][Full Text] [Related]
10. MiRNA-483-5p is involved in the pathogenesis of osteoporosis by promoting osteoclast differentiation.
Li K; Chen S; Cai P; Chen K; Li L; Yang X; Yi J; Luo X; Du Y; Zheng H
Mol Cell Probes; 2020 Feb; 49():101479. PubMed ID: 31706013
[TBL] [Abstract][Full Text] [Related]
11. miR-31 controls osteoclast formation and bone resorption by targeting RhoA.
Mizoguchi F; Murakami Y; Saito T; Miyasaka N; Kohsaka H
Arthritis Res Ther; 2013; 15(5):R102. PubMed ID: 24004633
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-155 inhibition up-regulates LEPR to inhibit osteoclast activation and bone resorption via activation of AMPK in alendronate-treated osteoporotic mice.
Mao Z; Zhu Y; Hao W; Chu C; Su H
IUBMB Life; 2019 Dec; 71(12):1916-1928. PubMed ID: 31317664
[TBL] [Abstract][Full Text] [Related]
13. Estrogen inhibits osteoclasts formation and bone resorption via microRNA-27a targeting PPARγ and APC.
Guo L; Chen K; Yuan J; Huang P; Xu X; Li C; Qian N; Qi J; Shao Z; Deng L; He C; Xu J
J Cell Physiol; 2018 Jan; 234(1):581-594. PubMed ID: 30272823
[TBL] [Abstract][Full Text] [Related]
14. The calcium channel TRPV6 is a novel regulator of RANKL-induced osteoclastic differentiation and bone absorption activity through the IGF-PI3K-AKT pathway.
Ma J; Zhu L; Zhou Z; Song T; Yang L; Yan X; Chen A; Ye TW
Cell Prolif; 2021 Jan; 54(1):e12955. PubMed ID: 33159483
[TBL] [Abstract][Full Text] [Related]
15. Aminothiazoles inhibit osteoclastogenesis and PGE
Kats A; Gerasimcik N; Näreoja T; Nederberg J; Grenlöv S; Lagnöhed E; Desai S; Andersson G; Yucel-Lindberg T
J Cell Mol Med; 2019 Feb; 23(2):1152-1163. PubMed ID: 30506812
[TBL] [Abstract][Full Text] [Related]
16. miR-145-5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin.
Chen Y; Wang X; Yang M; Ruan W; Wei W; Gu D; Wang J; Guo X; Guo L; Yuan Y
Med Sci Monit; 2018 Jul; 24():5292-5300. PubMed ID: 30059491
[TBL] [Abstract][Full Text] [Related]
17. MiR-125a-5p promotes osteoclastogenesis by targeting TNFRSF1B.
Sun L; Lian JX; Meng S
Cell Mol Biol Lett; 2019; 24():23. PubMed ID: 30976285
[TBL] [Abstract][Full Text] [Related]
18. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption.
Mizoguchi F; Izu Y; Hayata T; Hemmi H; Nakashima K; Nakamura T; Kato S; Miyasaka N; Ezura Y; Noda M
J Cell Biochem; 2010 Apr; 109(5):866-75. PubMed ID: 20039311
[TBL] [Abstract][Full Text] [Related]
19. miR-29 promotes murine osteoclastogenesis by regulating osteoclast commitment and migration.
Franceschetti T; Kessler CB; Lee SK; Delany AM
J Biol Chem; 2013 Nov; 288(46):33347-60. PubMed ID: 24085298
[TBL] [Abstract][Full Text] [Related]
20. The Role of miR-21 in Osteoblasts-Osteoclasts Coupling In Vitro.
Smieszek A; Marcinkowska K; Pielok A; Sikora M; Valihrach L; Marycz K
Cells; 2020 Feb; 9(2):. PubMed ID: 32093031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
